MDS experts, Dr Alan List and Dr David Sallman, provide an overview of the prognostic classification systems for
myelodysplastic syndromes (
MDS) that are used to predict outlook and decide on treatment options. The
International Prognostic Scoring System (IPSS) and the
Revised International Prognostic Scoring System (
IPSS-R) help determine if a patient has a lower risk or a higher risk of their MDS progressing into acute myeloid leukemia, and help doctors plan treatment.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.